Home / Tags / THCA

THCA

ICRS 2018: Report from Leiden (Part 2)

Fatty acid binding illustration

During the first week of July 2018, five-hundred-and-thirty-five delegates from five continents met at the University of Leiden in the Netherlands for the 28th annual symposium of the International Cannabinoid Research Society (ICRS). The four-day conference showcased recent scientific discoveries about cannabis components and various ways of targeting the endocannabinoid system to improve health outcomes.

Cannabis Hyperemesis Syndrome

Many of our patients have called in asking about cannabinoid hyperemesis syndrome (CHS), as this syndrome has been reported in the media numerous times over the past few months. This is a very rare syndrome that occurs in long-term heavy users of THC-rich cannabis. CHS was first reported in the medical literature in 2004. Symptoms include nausea, vomiting and abdominal pain.

Epilepsy, Endocannabinoids and Phytocannabinoids

Brain waves in epileptic

“David,” a 10 year old boy, had his first seizure at 2 months of age. The convulsions were photosensitive generalized tonic-clonic seizures that occurred 1-4 times each day. These events were occurring daily, even though he was being treated with two anti-seizure medications – lamotrigine (Lamictal) and valproic acid. But they had already tried carbamazepine, phenobarbital, zonisamide and levetiracetam (Keppra) without success.